Xponance’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Buy
33,510
+3,240
+11% +$860K 0.1% 163
2026
Q1
$3.32M Buy
30,270
+3,576
+13% +$509K 0.02% 445
2025
Q4
$4.44M Buy
26,694
+8,342
+45% +$1.4M 0.03% 360
2025
Q3
$3.59M Sell
18,352
-1,871
-9% -$308K 0.03% 403
2025
Q2
$1.83M Buy
20,223
+14,582
+259% +$1.15M 0.02% 556
2025
Q1
$337K Buy
5,641
+418
+8% +$38.7K ﹤0.01% 1060
2024
Q4
$692K Buy
+5,223
New +$490K 0.01% 850

Other funds holding ALAB

Xponance's ALAB Position: Q2 2026 in Review

Xponance increased its Astera Labs (ALAB) stake by 11% in Q2 2026, buying an estimated $860K and bringing the position to 33,510 shares worth $16.2M. The position accounts for 0.1% of the portfolio, ranked #163.

Xponance first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Xponance held 33,510 shares of Astera Labs worth $16.2M as of Q2 2026.
  • Xponance bought 3,240 Astera Labs shares in Q2 2026, an estimated $860K.
  • Astera Labs made up 0.1% of Xponance's portfolio in Q2 2026, its #163 holding.
  • Xponance first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.